Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NYSE American - Nasdaq Real Time Price USD

NovaBay Pharmaceuticals, Inc. (NBY)

Compare
0.5623
-0.0097
(-1.70%)
At close: April 3 at 4:00:00 PM EDT
0.5500
-0.01
(-2.19%)
After hours: April 3 at 6:27:57 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NBY

Recent News: NBY

View More

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
Business Wire 27 days ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
Business Wire 2 months ago
NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why
Zacks 3 months ago
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Business Wire 3 months ago
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
Business Wire 3 months ago
NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
Business Wire 4 months ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
Business Wire 4 months ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
Business Wire 4 months ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
Business Wire 4 months ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
Business Wire 5 months ago
Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
PR Newswire 6 months ago
View More

Related Tickers

MNOV MediciNova, Inc.
1.3400
-4.96%
 
ZVSA ZyVersa Therapeutics, Inc.
0.6090
+3.69%
 
IGC IGC Pharma, Inc.
0.2792
-1.13%
 
GLYC GlycoMimetics, Inc.
0.1851
-11.73%
 
ATNF 180 Life Sciences Corp.
0.8800
-12.00%
 
KLTO Klotho Neurosciences, Inc.
0.1771
-12.37%
 
INAB IN8bio, Inc.
0.1612
-5.51%
 
SPRC SciSparc Ltd.
0.3004
-0.83%
 
SLGL Sol-Gel Technologies Ltd.
0.5000
+3.31%
 
XFOR X4 Pharmaceuticals, Inc.
0.2100
-7.89%